Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

According to U.S. District Judge Matthew Kacsmaryk, the Biden administration's policy is inconsistent with legislation ...

U.S. Steel stock increased more than 16% in reaction to the decision to review the proposed merger with Nippon Steel for a second time.

Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as ...

In at least six letters published in the Seneca Courier-Tribune between January 2021 and March 2024, Hermesch airs his views ...

The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as ...

Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, General Motors is ...

President Trump is ordering a new review of the proposed merger between Nippon Steel and U.S. Steel from the Committee on Foreign Investment in the United States. The White House on Monday said the ...

The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden ...

Under Friday’s final ruling anti-obesity medications for weight-loss will remain ineligible for Medicare coverage.